Lonza Group stock dips despite solid recent results
Published on 09/12/2026 at 14:44 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Lonza Group stock (ISIN CH0013841017) closed at 531.20 Swiss francs on the Swiss Exchange on September 11, 2026, down 0.7 percent from the prior day’s 535.00 francs as trading volume reached 121,263 shares.
Stock softens after recent gains
According to the Swiss Exchange overview on September 11, 2026, Lonza Group shares traded in a daily range between 530.20 and 540.40 francs, with the closing price of 531.20 francs marking a modest decline of 3.80 francs, or 0.71 percent, compared with the previous close of 535.00 francs.
Market data from the same overview show that Lonza Group is part of the Swiss blue-chip universe and participates in specialist indices focused on Swiss small and mid-cap opportunities, where it accounts for 3.82 percent of one actively managed fund’s portfolio as of September 11, 2026, underscoring its role as a core exposure for domestic investors.
Recent fundamentals underpin the valuation
While the share price eased on September 11, 2026, the stock continues to be supported by the company’s most recently reported results and guidance, which investors still use as a benchmark for valuing Lonza Group’s contract development and manufacturing operations. In its latest interim reporting period within the past nine months, Lonza Group reported revenue and profitability figures that maintained its position as a key supplier to the pharmaceutical and biotech industry, and those results remain the fundamental backdrop against which the current share price of 531.20 francs is being assessed.
Historical comparison values from prior fiscal years show that Lonza Group has grown over time from smaller revenue and earnings bases to the present scale, but those older figures are now mainly relevant as a long-term trend reference rather than as current metrics for 2026. For investors, the interplay between the recent revenue trajectory and the margins achieved in the latest half-year or quarterly period is central to judging whether the current share price and modest daily move of minus 0.71 percent reflect an attractive risk-reward profile.
Lonza Group in Swiss portfolios
Lonza Group’s role in Swiss equity portfolios is highlighted by its inclusion in a Swiss small and mid-cap opportunities fund, where it made up 3.82 percent of holdings as of September 11, 2026, according to data from a fund overview that lists Lonza Group among its largest positions alongside other Swiss industrial and healthcare names.
The same fund information shows that the portfolio is denominated in Swiss francs, aligning well with Lonza Group’s primary listing currency and reinforcing the company’s status as a domestically important issuer. A fund price of 616.06 francs for the relevant share class on September 11, 2026, with a noted high of 660.47 francs and low of 571.90 francs over the observed period, illustrates how Lonza Group participates in the broader performance range of Swiss mid-cap equities through its weighting in the fund.
Stock price and investor takeaway
Lonza Group stock closed at 531.20 Swiss francs on the Swiss Exchange on September 11, 2026, 3.80 francs below the previous day’s 535.00 francs, which corresponds to a decline of 0.71 percent. For investors, that small pullback fits into a broader pattern in which Lonza Group remains a significant position in Swiss-focused equity funds and continues to be valued against its latest available operating figures.
Lonza Group stock facts
- Company: Lonza Group AG
- ISIN: CH0013841017
- Ticker: LONN
- Trading venue: SIX Swiss Exchange
- Price (as of September 11, 2026, 17:35): 531.20 CHF
- Market capitalization: [value] CHF (as of September 11, 2026)
- Sector / Industry: Healthcare - Contract development and manufacturing
- Index membership: Swiss equity indices including specialist small and mid-cap opportunities
